Boston Trust Walden Corp Charles River Laboratories International, Inc. Transaction History

Boston Trust Walden Corp

  • $13.4 Billion
  • Q3 2025

A detailed history of Boston Trust Walden Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 307,242 shares of CRL stock, worth $51.6 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
307,242
Previous 225,191 36.44%
Holding current value
$51.6 Million
Previous $34.2 Million 40.69%
% of portfolio
0.36%
Previous 0.25%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025
BUY
$145.57 - $178.99 $11.9 Million - $14.7 Million
82,051 Added 36.44%
307,242 $48.1 Million
Q2 2025

Jul 28, 2025
BUY
$99.75 - $151.89 $1.97 Million - $3.01 Million
19,789 Added 9.63%
225,191 $34.2 Million
Q1 2025

Apr 21, 2025
BUY
$150.52 - $190.14 $138,327 - $174,738
919 Added 0.45%
205,402 $30.9 Million
Q4 2024

Jan 24, 2025
BUY
$178.58 - $220.69 $1.49 Million - $1.84 Million
8,338 Added 4.25%
204,483 $37.7 Million
Q3 2024

Oct 24, 2024
SELL
$187.96 - $245.29 $783,605 - $1.02 Million
-4,169 Reduced 2.08%
196,145 $38.6 Million
Q2 2024

Jul 19, 2024
BUY
$206.39 - $268.73 $1.11 Million - $1.44 Million
5,375 Added 2.76%
200,314 $41.4 Million
Q1 2024

Apr 22, 2024
SELL
$203.52 - $273.43 $492,518 - $661,700
-2,420 Reduced 1.23%
194,939 $52.8 Million
Q4 2023

Jan 24, 2024
BUY
$164.52 - $238.84 $1.06 Million - $1.54 Million
6,462 Added 3.39%
197,359 $46.7 Million
Q3 2023

Oct 18, 2023
BUY
$194.44 - $217.61 $168,968 - $189,103
869 Added 0.46%
190,897 $37.4 Million
Q2 2023

Jul 24, 2023
BUY
$183.71 - $210.25 $2.89 Million - $3.31 Million
15,746 Added 9.03%
190,028 $40 Million
Q1 2023

Apr 19, 2023
BUY
$191.89 - $259.92 $6.47 Million - $8.76 Million
33,693 Added 23.97%
174,282 $35.2 Million
Q4 2022

Jan 20, 2023
BUY
$197.11 - $250.07 $7.95 Million - $10.1 Million
40,316 Added 40.21%
140,589 $0
Q3 2022

Oct 19, 2022
SELL
$182.44 - $250.54 $153,249 - $210,453
-840 Reduced 0.83%
100,273 $19.7 Million
Q2 2022

Jul 22, 2022
BUY
$204.13 - $302.4 $451,331 - $668,606
2,211 Added 2.24%
101,113 $21.6 Million
Q1 2022

Apr 20, 2022
BUY
$255.51 - $362.11 $3.69 Million - $5.23 Million
14,431 Added 17.08%
98,902 $28.1 Million
Q4 2021

Jan 21, 2022
BUY
$351.38 - $448.68 $298,321 - $380,929
849 Added 1.02%
84,471 $31.8 Million
Q3 2021

Oct 25, 2021
SELL
$372.64 - $458.3 $767,265 - $943,639
-2,059 Reduced 2.4%
83,622 $34.5 Million
Q2 2021

Jul 22, 2021
BUY
$294.17 - $371.65 $2.91 Million - $3.68 Million
9,899 Added 13.06%
85,681 $31.7 Million
Q1 2021

Apr 21, 2021
BUY
$249.67 - $299.48 $2.71 Million - $3.25 Million
10,839 Added 16.69%
75,782 $22 Million
Q4 2020

Jan 15, 2021
BUY
$222.0 - $252.62 $400,488 - $455,726
1,804 Added 2.86%
64,943 $16.2 Million
Q3 2020

Oct 14, 2020
BUY
$175.56 - $226.45 $173,628 - $223,959
989 Added 1.59%
63,139 $14.3 Million
Q2 2020

Jul 23, 2020
SELL
$118.84 - $189.72 $5.02 Million - $8.01 Million
-42,207 Reduced 40.44%
62,150 $10.8 Million
Q1 2020

Apr 24, 2020
SELL
$98.9 - $178.34 $2.48 Million - $4.47 Million
-25,085 Reduced 19.38%
104,357 $13.2 Million
Q1 2020

Apr 21, 2020
SELL
$98.9 - $178.34 $1.69 Million - $3.05 Million
-17,100 Reduced 11.67%
129,442 $16.3 Million
Q4 2019

Jan 10, 2020
BUY
$126.05 - $152.76 $225,755 - $273,593
1,791 Added 1.24%
146,542 $22.4 Million
Q3 2019

Oct 21, 2019
BUY
$125.07 - $143.67 $186,479 - $214,211
1,491 Added 1.04%
144,751 $19.2 Million
Q2 2019

Jul 25, 2019
SELL
$123.4 - $148.55 $182,632 - $219,854
-1,480 Reduced 1.02%
143,260 $20.3 Million
Q1 2019

Apr 16, 2019
BUY
$104.82 - $146.73 $268,653 - $376,068
2,563 Added 1.8%
144,740 $21 Million
Q4 2018

Jan 17, 2019
SELL
$105.09 - $137.23 $749,922 - $979,273
-7,136 Reduced 4.78%
142,177 $16.1 Million
Q3 2018

Oct 23, 2018
SELL
$112.11 - $134.54 $651,807 - $782,215
-5,814 Reduced 3.75%
149,313 $20.1 Million
Q2 2018

Jul 25, 2018
BUY
$102.37 - $117.25 $4.21 Million - $4.82 Million
41,134 Added 36.08%
155,127 $17.4 Million
Q1 2018

Apr 13, 2018
SELL
$98.19 - $115.2 $838,837 - $984,153
-8,543 Reduced 6.97%
113,993 $12.2 Million
Q4 2017

Jan 29, 2018
BUY
$100.43 - $118.09 $12.3 Million - $14.5 Million
122,536
122,536 $13.4 Million

Others Institutions Holding CRL

# of Institutions
644
Shares Held
51.7M
Call Options Held
201K
Put Options Held
179K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email